1165715-39-8

Basic information

• Product Name: (3β)-3-hydroxypregn-5-en-20-one 4-{4-[di(2-chloroethyl)amino]-3-nitro-phenyl}butyrate
• Synonyms: (3β)-3-hydroxypregn-5-en-20-one 4-{4-[di(2-chloroethyl)amino]-3-nitro-phenyl}butyrate
• CAS NO: 1165715-39-8
• Molecular Weight: 647.683
• Mol File: 1165715-39-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3β)-3-hydroxypregn-5-en-20-one 4-{4-[di(2-chloroethyl)amino]-3-nitro-phenyl}butyrate(CAS DataBase Reference)
• NIST Chemistry Reference: (3β)-3-hydroxypregn-5-en-20-one 4-{4-[di(2-chloroethyl)amino]-3-nitro-phenyl}butyrate(1165715-39-8)
• EPA Substance Registry System: (3β)-3-hydroxypregn-5-en-20-one 4-{4-[di(2-chloroethyl)amino]-3-nitro-phenyl}butyrate(1165715-39-8)

Safety Data

• Hazardous Substances Data: 1165715-39-8(Hazardous Substances Data)

Upstream product

• 145-13-1 Pregnenolone 

Downstream Products

• 305-03-3 chlorambucil 

Relevant articles and documents

To determine the cytotoxicity of chlorambucil and one of its nitro-derivatives, conjugated to prasterone and pregnenolone, towards eight human cancer cell-lines

Four ester prodrugs derived from the bifunctional alkylating agent chlorambucil, and one of its nitro-derivatives, 3-nitrochlorambucil conjugated to prasterone and pregnenolone, were synthesized and tested for their cytotoxic activity against eight human cell lines, using the standard MTT assay. A comparison between the esters and the controls, namely chlorambucil and 3-nitrochlorambucil would suggest that all four esters possess to varying degrees, specificity towards the breast adenocarcinoma cell line (MDA-mb468) than the other seven cells' lines tested. The overall findings are encouraging since it infers that these lipophilic esters not only have the ability to traverse specific cell membranes but also exhibit cytotoxicity towards most of the cell lines tested.